Total Payments
$3,035
2024 Payments
$381.03
Companies
24
Transactions
214
Medicare Patients
1,418
Medicare Billing
$183,074
Payment Breakdown by Category
Food & Beverage$2,953 (97.3%)
Education$81.46 (2.7%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,953 | 210 | 97.3% |
| Education | $81.46 | 4 | 2.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $703.07 | 62 | $0 (2024) |
| ABBVIE INC. | $643.03 | 43 | $0 (2024) |
| PFIZER INC. | $275.54 | 25 | $0 (2024) |
| Genentech USA, Inc. | $240.02 | 20 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $149.02 | 9 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $144.11 | 5 | $0 (2024) |
| Lilly USA, LLC | $131.06 | 7 | $0 (2024) |
| Horizon Pharma plc | $120.63 | 8 | $0 (2018) |
| Horizon Therapeutics plc | $115.05 | 6 | $0 (2023) |
| GlaxoSmithKline, LLC. | $99.33 | 6 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $381.03 | 19 | ABBVIE INC. ($75.12) |
| 2023 | $689.60 | 54 | AbbVie Inc. ($195.29) |
| 2022 | $403.64 | 23 | ABBVIE INC. ($166.00) |
| 2021 | $47.03 | 3 | AbbVie Inc. ($23.23) |
| 2020 | $93.77 | 5 | AbbVie Inc. ($59.40) |
| 2019 | $384.15 | 25 | GlaxoSmithKline, LLC. ($47.56) |
| 2018 | $616.23 | 49 | Amgen Inc. ($199.60) |
| 2017 | $419.05 | 36 | Amgen Inc. ($197.68) |
All Payment Transactions
214 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $19.71 | General |
| Category: IMMUNOLOGY | ||||||
| 10/24/2024 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $22.15 | General |
| 10/17/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $21.23 | General |
| Category: Inflammation | ||||||
| 10/15/2024 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $21.22 | General |
| Category: Immunology | ||||||
| 09/10/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $21.76 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 09/09/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $23.49 | General |
| Category: Cardiology | ||||||
| 09/03/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $13.48 | General |
| Category: Dermatology | ||||||
| 08/20/2024 | Bioventus LLC | DUROLANE (Device) | Food and Beverage | In-kind items and services | $15.66 | General |
| Category: ORTHOPEDICSORTHOPEDIC SURGERY | ||||||
| 08/12/2024 | E.R. Squibb & Sons, L.L.C. | ORENCIA (Biological) | Food and Beverage | Cash or cash equivalent | $22.84 | General |
| Category: Immunology | ||||||
| 07/16/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $30.49 | General |
| Category: IMMUNOLOGY | ||||||
| 06/06/2024 | GENZYME CORPORATION | KEVZARA (Biological) | Food and Beverage | In-kind items and services | $13.72 | General |
| Category: Rheumatology | ||||||
| 05/06/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $24.26 | General |
| Category: Dermatology | ||||||
| 04/30/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $20.72 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 04/29/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: Inflammation | ||||||
| 04/25/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $13.31 | General |
| Category: Immunology | ||||||
| 04/03/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $24.92 | General |
| Category: IMMUNOLOGY | ||||||
| 03/19/2024 | Genentech USA, Inc. | Actemra (Biological) | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: Immunology | ||||||
| 01/30/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $19.56 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 01/03/2024 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $23.01 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 12/13/2023 | AbbVie Inc. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $10.93 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2023 | PFIZER INC. | XELJANZ (Drug), COMIRNATY | Food and Beverage | In-kind items and services | $7.38 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/06/2023 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $9.78 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/05/2023 | AbbVie Inc. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $15.31 | General |
| Category: IMMUNOLOGY | ||||||
| 12/01/2023 | AbbVie Inc. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $9.33 | General |
| Category: IMMUNOLOGY | ||||||
| 11/21/2023 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $21.74 | General |
| Category: Dermatology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 401 | 582 | $112,155 | $51,241 |
| 2022 | 8 | 387 | 576 | $105,105 | $46,918 |
| 2021 | 5 | 323 | 450 | $88,725 | $47,360 |
| 2020 | 4 | 307 | 485 | $85,432 | $37,556 |
Total Patients
1,418
Total Services
2,093
Medicare Billing
$183,074
Procedure Codes
24
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 198 | 320 | $63,920 | $28,031 | 43.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 80 | 80 | $20,816 | $9,867 | 47.4% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 72 | 87 | $16,617 | $8,035 | 48.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 13 | 17 | $4,556 | $2,384 | 52.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 14 | 14 | $4,592 | $2,127 | 46.3% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 12 | 14 | $1,504 | $753.98 | 50.1% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 12 | 50 | $150.00 | $42.45 | 28.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 206 | 329 | $65,122 | $28,075 | 43.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 62 | 62 | $15,934 | $7,868 | 49.4% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 38 | 40 | $7,920 | $3,803 | 48.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 23 | 25 | $6,950 | $3,055 | 44.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 20 | 20 | $6,780 | $2,920 | 43.1% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 13 | 16 | $1,667 | $832.18 | 49.9% |
| 99406 | Smoking and tobacco use intensive counseling, 4-10 minutes | Office | 2022 | 14 | 20 | $480.00 | $313.44 | 65.3% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 11 | 64 | $252.00 | $51.52 | 20.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 206 | 323 | $60,724 | $31,759 | 52.3% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 35 | 37 | $9,731 | $5,465 | 56.2% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 28 | 28 | $8,960 | $4,940 | 55.1% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 36 | 36 | $8,712 | $4,796 | 55.1% |
| 99406 | Smoking and tobacco use intermediate counseling, greater than 3 minutes up to 10 minutes | Office | 2021 | 18 | 26 | $598.00 | $399.25 | 66.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 235 | 413 | $69,278 | $30,879 | 44.6% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 46 | 46 | $11,638 | $4,785 | 41.1% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 14 | 14 | $3,136 | $1,201 | 38.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 12 | 12 | $1,380 | $690.25 | 50.0% |
About Dr. Rupal Chavda, MD
Dr. Rupal Chavda, MD is a Rheumatology healthcare provider based in Pueblo, Colorado. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/10/2010. The National Provider Identifier (NPI) number assigned to this provider is 1760799894.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Rupal Chavda, MD has received a total of $3,035 in payments from pharmaceutical and medical device companies, with $381.03 received in 2024. These payments were reported across 214 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($2,953).
As a Medicare-enrolled provider, Chavda has provided services to 1,418 Medicare beneficiaries, totaling 2,093 services with total Medicare billing of $183,074. Data is available for 4 years (2020–2023), covering 24 distinct procedure/service records.
Ad
Practice Information
- Specialty Rheumatology
- Other Specialties Rheumatology
- Location Pueblo, CO
- Active Since 09/10/2010
- Last Updated 09/02/2016
- Taxonomy Code 207RR0500X
- Entity Type Individual
- NPI Number 1760799894
Products in Payments
- Enbrel (Biological) $593.54
- RINVOQ (Biological) $459.64
- XELJANZ (Drug) $275.54
- Rituxan (Biological) $160.75
- SAPHNELO (Biological) $144.11
- TALTZ (Drug) $131.06
- Humira (Biological) $123.99
- BENLYSTA (Biological) $99.33
- KRYSTEXXA (Biological) $91.11
- Actemra (Biological) $79.27
- ACTHAR (Biological) $77.15
- COSENTYX (Biological) $73.84
- KRYSTEXXA (Drug) $72.37
- RAYOS (Drug) $72.20
- TREMFYA (Drug) $68.30
- COSENTYX (Drug) $59.48
- AMJEVITA (Biological) $51.04
- RENFLEXIS (Biological) $47.14
- RINVOQ (Drug) $46.49
- Cimzia (Drug) $39.65
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.